- Home
- CRDL vs KRMD Comparison
CRDL vs KRMD Comparison
Compare CRDL & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- KRMD
- Stock Information
- Founded
- CRDL 2017
- KRMD 1980
- Country
- CRDL Canada
- KRMD United States
- Employees
- CRDL N/A
- KRMD N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- KRMD Medical/Dental Instruments
- Sector
- CRDL Health Care
- KRMD Health Care
- Exchange
- CRDL Nasdaq
- KRMD Nasdaq
- Market Cap
- CRDL 142.5M
- KRMD 145.4M
- IPO Year
- CRDL N/A
- KRMD N/A
- Fundamental
- Price
- CRDL $1.58
- KRMD $3.61
- Analyst Decision
- CRDL Strong Buy
- KRMD Strong Buy
- Analyst Count
- CRDL 3
- KRMD 4
- Target Price
- CRDL $9.00
- KRMD $4.13
- AVG Volume (30 Days)
- CRDL 421.9K
- KRMD 45.6K
- Earning Date
- CRDL 11-14-2024
- KRMD 11-13-2024
- Dividend Yield
- CRDL N/A
- KRMD N/A
- EPS Growth
- CRDL N/A
- KRMD N/A
- EPS
- CRDL N/A
- KRMD N/A
- Revenue
- CRDL N/A
- KRMD $31,993,796.00
- Revenue This Year
- CRDL N/A
- KRMD $15.46
- Revenue Next Year
- CRDL N/A
- KRMD $17.47
- P/E Ratio
- CRDL N/A
- KRMD N/A
- Revenue Growth
- CRDL N/A
- KRMD 11.57
- 52 Week Low
- CRDL $0.79
- KRMD $1.98
- 52 Week High
- CRDL $3.12
- KRMD $3.69
- Technical
- Relative Strength Index (RSI)
- CRDL 30.69
- KRMD 69.62
- Support Level
- CRDL $1.83
- KRMD $2.97
- Resistance Level
- CRDL $1.92
- KRMD $3.69
- Average True Range (ATR)
- CRDL 0.15
- KRMD 0.24
- MACD
- CRDL -0.04
- KRMD 0.07
- Stochastic Oscillator
- CRDL 12.00
- KRMD 82.12
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).